Unlocking the Future of the Mineral And Bone Disorder Treatment Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the Mineral And Bone Disorder Treatment market grown over the years?
In the past few years, there has been a robust growth in the market size for mineral and bone disorder treatment. The market is projected to increase from $3.3 billion in 2024 to $3.55 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%. Factors such as the prevalence of chronic kidney disease, an aging populace, greater comprehension of mineral and bone disorders, more accessible treatments for these disorders, and surging disposable income levels contribute to the growth experienced in the historic period.
What Is the forecasted market size and growth rate for the mineral and bone disorder treatment market?
The market size for the treatment of mineral and bone disorder is predicted to experience significant expansion in the following years. The market is expected to rise to $4.68 billion by 2029, with a compound annual growth rate (CAGR) of 7.1%. The potential growth during this projected period can be credited to an increase in the need for quality of life treatments, a surge in the preference for personalized medicine, government investment in healthcare, and a heightened awareness of the critical nature of early diagnosis. Notable trends expected during this forecast period include advancements in medical studies, evolutions in the pharmaceutical industry, the rise of digital health and biologic therapies, telehealth, and distance monitoring.
Get your mineral and bone disorder treatment market report here!
What are the major factors driving growth in the mineral and bone disorder treatment market?
The upsurge in the elderly population is anticipated to fuel the expansion of the mineral and bone disorder treatment market. The term “elderly population” refers to individuals aged 65 years and above. As age advances, individuals often suffer from loss of muscle and bone mass, leading to frailty and diminished strength. Treatments associated with minerals and bone disorders can aid in alleviating age-related muscle, bone, and joint changes, fortify bones, and slow down bone loss. For instance, the House of Commons Library of the UK Parliament – a government administration based in the UK, projected in July 2024, that by 2022 there would be 12.7 million people or 19% of the UK population aged 65 and above. This number is expected to surge to 22.1 million (27% of the population) by 2072. Hence, the growth in the elderly population is a significant driver for the mineral and bone disorder treatment market.
Mineral And Bone Disorder Treatment Market Driver: The Rising Occurrence Of Chronic Kidney Diseases Fuels The Expansion Of The Mineral And Bone Disorder Treatment Market
What key areas define the segmentation of the global mineral and bone disorder treatment Market?
The mineral and bone disorder treatment market covered in this report is segmented –
1) By Treatment: Diet, Nutrition, Medication, Supplements, Dialysis
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Diet: Calcium-Rich Foods, Vitamin D-Enriched Foods, Phosphorus-Rich Foods
2) By Nutrition: Nutritional Counseling, Fortified Food Products, Meal Replacement Programs
3) By Medication: Bisphosphonates, Hormonal Therapies, RANK Ligand Inhibitors
4) By Supplements: Calcium Supplements, Vitamin D Supplements, Multivitamin Supplements
5) By Dialysis: Hemodialysis, Peritoneal Dialysis, Continuous Renal Replacement Therapy (CRRT)
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12956&type=smp
What are the top market players propelling the growth of the mineral and bone disorder treatment industry?
Major companies operating in the mineral and bone disorder treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Co. Ltd., Eli Lilly And Company, Amgen Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Mylan N.V., Daiichi Sankyo Company Limited, Servier Laboratories Pty Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Zydus Cadila Healthcare Ltd., Alembic Pharmaceuticals Limited, Ajanta Pharma Ltd., Abiogen Pharma Spa, Melinta Therapeutics Inc., Intas Pharmaceuticals Ltd., Radius Health Inc., EffRx Pharmaceuticals SA.
What are the key trends shaping the future of the mineral and bone disorder treatment market?
Leading businesses in the mineral and bone disorder treatment industry are solidifying their market presence by innovating and obtaining approvals for new products. The rise in approvals for mineral and bone medications can be attributed to a growing aging population and a rise in chronic kidney disorders like diseases treated with TYMLOS (abaloparatide). This drug, a lab-engineered version of the human parathyroid hormone, contains the active ingredient abaloparatide. For example, in December 2022, Radius Health Inc., an American biopharmaceutical enterprise, got approval for TYMLOS (abaloparatide), a synthetic parathyroid hormone-related protein PTHrP(1-34) analog, intended to boost bone density in osteoporotic men at a high risk of fractures. This drug functions as a bone anabolic agent, selectively activating the parathyroid hormone 1 receptor (PTH1R) found in osteoblasts and osteocytes, thereby enhancing bone formation and density.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
What regions are dominating the mineral and bone disorder treatment market growth?
North America was the largest region in the mineral and bone disorder treatment market in 2024. The regions covered in mineral and bone disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Blood Collection Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-collection-devices-global-market-report
Blood Culture Tests Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-culture-tests-global-market-report
Patient Blood Management Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
